PODCAST
Hair Loss, Hot Flash Breakthroughs, and the ADHD Connection
April 27, 2026·8:59·Episode 23
Quick Summary
A systematic review shows estrogen therapy may help with menopausal hair loss. A new non-hormonal drug GS1-144 targets hot flash mechanisms directly. And experts are exploring why ADHD diagnoses are rising in menopausal women as estrogen decline affects dopamine and focus.
Hair Loss, Hot Flash Breakthroughs, and the ADHD Connection
0:000:00
Key Takeaways
- ✦Estrogen therapy shows promise for menopausal hair loss, but results vary and early treatment seems to work better
- ✦GS1-144, a neurokinin 3 receptor antagonist, significantly reduced hot flash frequency and severity in a phase 2 trial
- ✦More women in their 40s and 50s are being diagnosed with ADHD for the first time, possibly linked to declining estrogen affecting dopamine
- ✦Focus and attention issues that persist despite menopause treatment may warrant an ADHD evaluation
Sources & References
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.